Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Applying to UT Southwestern Clinical Center at Richardson/Plano · Richardson, Texas
Answer a few short questions to share with the research team.